Our Health Care Litigation Team discusses a District of Massachusetts case holding that allows the government to switch liability theories in its False Claims Act lawsuit against Regeneron Pharmaceuticals....more
8/11/2025
/ Anti-Kickback Statute ,
Department of Justice (DOJ) ,
Discovery ,
False Claims Act (FCA) ,
Healthcare Fraud ,
Litigation Strategies ,
Medicare ,
Pharmaceutical Industry ,
Popular ,
Regeneron ,
Summary Judgment
Our Health Care Group discusses a First Circuit case holding that could have a significant impact in establishing “but-for” causation as the majority standard....more